What is Insulin degludec?

Category: Prescription Drugs

Most popular types: Tresiba

false

Insulin degludec is a formulation of basal insulin that is considered to be ultra-long acting. 

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 0
Mild 0
None 5

Commonly reported side effects and conditions associated with Insulin degludec

Side effect Patients Percentage

Dosages

Based on patients currently taking Insulin degludec

Dosage Patients Percentage
26 intl units daily 1
120 other daily 1
200 units daily 1
3500 units daily 1

Why patients stopped taking Insulin degludec

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 1
Other 1
See all 3 patients who've stopped taking Insulin degludec

Duration

Currently taking Insulin degludec

Duration Patients Percentage
1 - 2 years 3
2 - 5 years 1

Stopped taking Insulin degludec

Duration Patients Percentage
1 - 6 months 2
1 - 2 years 1
Adherence
Adherence Evaluations Percentage
Always 4
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations Percentage
Very hard to take 1
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 4
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 0
$25-49 1
< $25 2
Not specified 2

What people switch to and from

Patients started taking Insulin degludec after stopping:

Treatment Patients Percentage
Insulin Glargine (Lantus) 9
Insulin Lispro (Humalog) 3
insulin detemir (Levemir FlexPen) 2
Insulin NPH (Novolin N) 1
Insulin NPH-insulin regular (Humulin Mix 70/30) 1

Patients stopped taking Insulin degludec and switched to:

Treatment Patients Percentage
insulin detemir (Levemir FlexPen) 1
Last updated:
There are no evaluations for Insulin degludec.